Similar Papers

Paper Title
Journal
Date
Author
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma
T Powles ... G De Velasco
Annals of Oncology | VOL. 32
T Powles, et. al.T Powles ... G De Velasco
28 Sep 2021
Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases
Daisuke Matsumoto ... Shinji Kato
IJU Case Reports | VOL. -
Daisuke Matsumoto, et. al.Daisuke Matsumoto ... Shinji Kato
22 Sep 2024
Reply by the authors to a letter by Chueh et al. (Urology 2010;77:253-254)
Matthew K Tollefson ... George K Chow
Urology | VOL. 77
Matthew K Tollefson, et. al.Matthew K Tollefson ... George K Chow
01 Feb 2011
Axitinib: Oral tyrosine kinase inhibitor for renal cell carcinoma
Maria G Tanzi
Pharmacy Today | VOL. 18
Maria G TanziMaria G Tanzi
01 Mar 2012
View more papers

More From: IJU Case Reports

Paper Title
Journal
Date
Author
Intravesical fungus ball following robot‐assisted radical prostatectomy in diabetes mellitus patient
Toru Suzuki ... Mutsunobu Yoshioka
IJU Case Reports | VOL. -
Toru Suzuki, et. al.Toru Suzuki ... Mutsunobu Yoshioka
06 Feb 2025
A successful case of urinary rediversion from a complicated cutaneous ureterostomy to a new ileal conduit
Yu Tashiro ... Masaaki Ito
IJU Case Reports | VOL. -
Yu Tashiro, et. al.Yu Tashiro ... Masaaki Ito
03 Feb 2025
A case of multiple bone metastases during the course of non‐invasive bladder and prostate cancer
Keisuke Matsubara ... Eiji Kikuchi
IJU Case Reports | VOL. -
Keisuke Matsubara, et. al.Keisuke Matsubara ... Eiji Kikuchi
02 Feb 2025
Recurrence of seminoma 48 years after orchiectomy: Longest late recurrence and treatment
Shinya Miyazaki ... Osamu Ukimura
IJU Case Reports | VOL. -
Shinya Miyazaki, et. al.Shinya Miyazaki ... Osamu Ukimura
30 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.